Skip to Main Content
Noninvasive early disease diagnosis by electronic-nose and related VOC-detection devicesAuthor(s): A. Dan Wilson
Publication Series: Scientific Journal (JRNL)
Station: Southern Research Station
Download Publication (175.0 KB)
DescriptionThis editorial provides an overview and summary of recent research articles published in Biosensors journal, volumes 9 (2019) and 10 (2020), within the Special Issue “Noninvasive Early Disease Diagnosis”, which focused on recent sensors, biosensors, and clinical instruments developed for the noninvasive early detection and diagnosis of human, animal, and plant diseases or invasive pests. The six research articles included in this Special Issue provide examples of some of the latest electronic-nose (e-nose) and related volatile organic compound (VOC)-detection technologies, which are being tested and developed to improve the effectiveness and efficiency of innovative diagnostic methodologies for the early detection of particular diseases and pest infestations in living hosts, prior to symptom development.
- You may send email to firstname.lastname@example.org to request a hard copy of this publication.
- (Please specify exactly which publication you are requesting and your mailing address.)
- We recommend that you also print this page and attach it to the printout of the article, to retain the full citation information.
- This article was written and prepared by U.S. Government employees on official time, and is therefore in the public domain.
CitationWilson, A.D. 2020. Noninvasive early disease diagnosis by electronic-nose and related VOC-detection devices. Biosensors 10, 73. (6 pp.)
Keywordsearly disease detection, clinical pathology, electronic nose, disease diagnostics, point-of-care testing, chemical sensors, disease biomarkers, metabolomics, volatile organic compounds (VOCs), White-nose Syndrome, Emerald ash borer
- Advances in electronic-nose technologies for the detection of volatile biomarker metabolites in the human breath
- Applications of electronic-nose technologies for noninvasive early detection of plant, animal and human diseases
- Biomarker metabolite signatures pave the way for electronic-nose applications in early clinical disease diagnoses
XML: View XML